Fortunato Ciardiello’s research areas of expertise cover the role of growth factor receptor-driven signaling pathways in human cancer development and progression and the possibility of defining selective molecular targeted therapies for cancer. In particular, Fortunato Ciardiello has played a major role in discovering and implementing the epidermal growth factor receptor (EGFR) as a therapeutic target in human colorectal and lung cancers. As recorded in Scopus, he has authored 500 scientific publications with 33799 citations and H Index of 80 (accessed on February 5, 2020).